Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins

Biological Chemistry

Volumn 382, Issue 3, 2001, Pages 499-504

  Rosenhagen, M C ^a   Young, J C ^a   Wochnik, G M ^a   Herr, A S ^a   Schmidt, U ^a   Hartl, F U ^a   Holsboer, F ^a   Rein, T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Geldanamycin; Heat shock protein 90; Herbimycin A

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; 17 ALLYLAMINO HERBIMYCIN; 19 ALLYLAMINO HERBIMYCIN; ANSAMYCIN DERIVATIVE; ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; CELL NUCLEUS RECEPTOR; DIMER; GELDANAMYCIN; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 90; HERBIMYCIN; HERBIMYCIN DERIVATIVE; PHOSPHOTRANSFERASE; RADICICOL; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG METABOLISM; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HORMONE BINDING; HUMAN; HUMAN CELL; MODEL; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSACTIVATION;

ANTI-BACTERIAL AGENTS; BENZOQUINONES; DRUG SYNERGISM; HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; LACTONES; MACROLIDES; QUINONES; RECEPTORS, GLUCOCORTICOID; SACCHAROMYCES CEREVISIAE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035035421     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.063     Document Type: Article

References (27)

1. Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity
2. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin
3. Molecular basis of agonism and antagonism in the oestrogen receptor
4. Hsp90's secrets unfold: New insights from structural and functional studies
5. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates
6. Rifampicin is not an activator of the glucocorticoid receptor
7. DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90
8. Monomer arrangement in HSP90 dimer as determined by decoration with N and C-terminal region specific antibodies
9. Molecular chaperones: The busy life of Hsp90
10. Mutational analysis of Hsp90 function: Interactions with a steroid receptor and a protein kinase
11. Regulation of glucocorticoid receptor by the tyrosine kinase inhibitor herbimycin A in the cytosolic fraction of primary cultured rat hepatocytes
12. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis
13. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
14. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone
15. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin
16. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding
17. Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
18. erbB-2 oncogene inhibition by geldanamycin derivatives: Synthesis, mechanism of action, and structure-activity relationships
19. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
20. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin
21. The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin
22. Differential signal transduction by five splice variants of the PACAP receptor
23. Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent
24. Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
25. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1aP-glycoprotein gene disruption
26. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells
27. Polypeptide release by Hsp90 involves ATP hydrolysis and is enhanced by the co-chaperone p23